Take Action Now to Make Child Care Centers Safer

Elijah’s Law is a bill named in memory of Elijah Silvera.  

On Nov. 3, 2017, 3-year-old Elijah died after a severe allergic reaction called anaphylaxis at his child care center.  

Elijah’s parents, Thomas Silvera and Dina Hawthorne, set out to ensure protections are in place in all child care centers. Working with their state lawmakers in New York, Elijah’s parents drafted the first Elijah’s Law. The bill ensures child care centers take steps to manage food allergies for the children in their care. 

The law has been introduced in 6 states this year: California, Kansas, Maryland, Michigan, Missouri, and Pennsylvania. 

If you live in one of those states, you can click the link above and ask your legislators to pass the bill this year. 

In Maryland, the bill has passed the House and Senate, and Gov. Wes Moore signed it into law, so your letter will thank Gov. Moore for making Maryland the fourth state to enact this legislation.  

Read our blog to learn more about Elijah’s Law and take action today. 

May Is National Asthma and Allergy Awareness Month

Each year since 1984, AAFA declares May as National Asthma and Allergy Awareness Month. Recently, AAFA sent a letter to President Biden asking him to formally recognize May to be National Asthma and Allergy Awareness Month. The letter highlights the importance of promoting awareness, education, and understanding of these diseases. 

Send your voice to the White House and ask President Biden to declare May National Asthma and Allergy Awareness Month. 

Join us as we work together to raise awareness, save lives, and improve the quality of life for people living with asthma and allergies! 

Donate $40 today in celebration of the 40th year of National Asthma and Allergy Awareness Month. 

RESEARCH NEWS

Our April 2024 research update includes summaries on current clinical trials, surveys, and study outcomes on the following topics: 

• FASENRA Approved for Treatment of Children Aged 6 to 11 with Severe Asthma 

• Poor Asthma and Allergy Control Is Linked to Lower Health-Related Quality of Life 

• Gaps in Care Among People with Uncontrolled Severe Asthma in the United States 

To learn more about this month’s asthma and allergy news, visit our blog. 

CLINICAL TRIALS

Are You Currently Taking Oral Corticosteroids (OCS) for Your Asthma?

Would you like to contribute to important new research? SUNRISE is a clinical study investigating whether a new biologic treatment called tezepelumab may help to reduce or remove the need for OCS in adults with severe asthma. The study is looking for people who:

• Are between 18 and 80 years of age
• Have had an asthma diagnosis for at least 1 year
• Have been taking OCS for asthma for at least 6 months
• Have been using inhaled corticosteroids for at least a year, and a long-acting beta 2-agonist (LABA) for at least 3 months
• Have not been receiving any biologic treatment for asthma for at least 4 months

Sponsored by AstraZeneca
 

LEARN MORE

CME OPPORTUNITIES

Health care professionals: Earn AMA PRA Category 1 Credit™ by watching our continuing medical education (CME) programs on chronic rhinosinusitis with nasal polyps (CRSwNP), available on demand.  

• Caring for Patients with Nasal Polyps in 2023: When to Consider a Biologic or Surgery? 

• Surgery or Biologic for Nasal Polyps? A Close Look at the Evidence 

• Cases in Practice: Applying Proposed Care Pathways for Interdisciplinary Collaboration to the Management of Nasal Polyps 

• Diagnostic Workup of the Patient with Uncontrolled Severe Nasal Polyps: Proposed Pathway to Determine Candidacy for Biologic Therapy 

You can find more information about these CME opportunities and many others at: aafa.org/cme 

Did You Miss Our Previous Issue?

Check out our most recent issue for news on inhaler costs going down, tips for a healthier home, and information on seasonal allergy management.  

                                   READ THE PREVIOUS ISSUE

Thank you for your continued support.
Visit aafa.org and kidswithfoodallergies.org